Company: IONQ
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059289
Chunk: 54

Company: IonQ, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 54
---
000 |     |    115,300 |    |  1,352,779 |     | 1,180,449 |     |              — |     |            — |       |  2,963,528 |

(1) The amounts in these columns reflect the aggregate grant date fair value of the shares underlying restricted stock unit awards, performance-based restricted stock unit awards, and option awards granted in the applicable year, computed in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718 for stock-based compensation transactions. The assumptions we used in valuing these awards are described in Note 16 to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on February 26, 2025 and do not necessarily correspond to the actual economic value recognized or that may be recognized by the NEOs. (2) See the section titled “ Compensation Discussion and Analysis—Executive Compensation Program Components—Long-Term Incentive Compensation ” above for a description of the material terms of the program pursuant to which this compensation was awarded. For performance-based restricted stock units, the amount reported represents the grant-date fair value based upon the probable outcome of the performance conditions for such awards, consistent with the estimate of aggregate compensation cost to be recognized over the service period determined as of the grant date under FASB ASC Topic 718, excluding the effect of estimated forfeitures, which yields a grant-date fair value for such awards granted of $12,169,873 for Mr. Chapman, and a grant-date fair value for such awards granted in 2023 of $7,140,173 for Mr. Kramer, $5,192,854 for Ms. Alameddine, and $7,789,289 for Dr. Kim. If maximum performance were deemed achieved for the performance-based restricted stock unit awards for which the performance conditions have been determined, the grant-date fair value of such awards granted in 2024 would be $14,559,839 for Mr. Chapman and the grant-date fair value of such awards granted in 2023 would be $19,520,755 for Mr. Kramer, $14,196,917 for Ms. Alameddine, and $21,295,396 for Dr. Kim. In connection with Dr. Kim's resignation as an employee, Dr. Kim forfeited his PSU award granted in August 2023 in its entirety. (